www.MarketResearchReports.com
Category : Pharma & Healthcare
All logos and Images mentioned on this slide belong to their ...
www.MarketResearchReports.com
Introduction to Report
 Launch Date: March 31, 2014
 Number of Pages: 366
 Geography Cove...
www.MarketResearchReports.com
About the Report
Methicillin-Resistant Staphylococcus Aureus (MRSA)
Infections Pipeline Revi...
www.MarketResearchReports.com
Scope:
The report provides a snapshot of the global therapeutic
landscape of Methicillin-Re...
www.MarketResearchReports.com
Scope Continues:
A review of the Methicillin-Resistant Staphylococcus Aureus
(MRSA) Infecti...
www.MarketResearchReports.com
Reason to Buy:
Provides strategically significant competitor information, analysis, and
ins...
www.MarketResearchReports.com
Report Coverage
1. Introduction
2. Late Stage Products
3. Drug Profiles
4. Appendix
5. Metho...
www.MarketResearchReports.com
Company Coverage(Partial List)
1. Eli Lilly and Company
2. Genentech, Inc.
3. AmpliPhi Biosc...
www.MarketResearchReports.com
Custom Research:
 Are you an industry professional, entrepreneur,
venture capitalist, inves...
www.MarketResearchReports.com
How To Buy This Report?
Visit following URL to see Table of Content and
purchase this public...
Upcoming SlideShare
Loading in …5
×

Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections - Pipeline Review, H1 2014

420 views

Published on

Market Research Reports, Inc. has announced the addition of “Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections - Pipeline Review, H1 2014” research report to their offering. See more at- http://mrr.cm/Zds

Published in: Health & Medicine, Business
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
420
On SlideShare
0
From Embeds
0
Number of Embeds
5
Actions
Shares
0
Downloads
5
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections - Pipeline Review, H1 2014

  1. 1. www.MarketResearchReports.com Category : Pharma & Healthcare All logos and Images mentioned on this slide belong to their respective owners.
  2. 2. www.MarketResearchReports.com Introduction to Report  Launch Date: March 31, 2014  Number of Pages: 366  Geography Coverage: Global  Available Format: PDF Price For Single User License: USD 2,000 Price For Site License: USD 4,000 Price For Global User License: USD 6,000 Delivery Time: Within 24 Hours (During Working Days)
  3. 3. www.MarketResearchReports.com About the Report Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections Pipeline Review, H1 2014 provides an overview of the Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases.
  4. 4. www.MarketResearchReports.com Scope: The report provides a snapshot of the global therapeutic landscape of Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities The report reviews key players involved in the therapeutics development for Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections and enlists all their major and minor projects The report summarizes all the dormant and discontinued pipeline projects
  5. 5. www.MarketResearchReports.com Scope Continues: A review of the Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections products under development by companies and universities/research institutes based on information derived from company and industry-specific sources Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages A detailed assessment of monotherapy and combination therapy pipeline projects Coverage of the Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections pipeline on the basis of target, MoA, route of administration and molecule type Latest news and deals relating related to pipeline products
  6. 6. www.MarketResearchReports.com Reason to Buy: Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage Develop strategic initiatives by understanding the focus areas of leading companies Identify and understand important and diverse types of therapeutics under development for Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline Devise corrective measures for pipeline projects by understanding Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections pipeline depth and focus of Indication therapeutics Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline
  7. 7. www.MarketResearchReports.com Report Coverage 1. Introduction 2. Late Stage Products 3. Drug Profiles 4. Appendix 5. Methodology For more details regarding Report coverage see the last slide All logos and Images mentioned on this slide belong to their respective owners.
  8. 8. www.MarketResearchReports.com Company Coverage(Partial List) 1. Eli Lilly and Company 2. Genentech, Inc. 3. AmpliPhi Biosciences Corporation 4. Takeda Pharmaceutical Company Limited 5. Piramal Enterprises Limited 6. Melinta Therapeutics, Inc 7. Aphios Corporation 8. Cubist Pharmaceuticals, Inc. 9. The Medicines Company 10. Wockhardt Limited 11. Paratek Pharmaceuticals, Inc. 12. Alchemia Limited For more details regarding Report coverage see the last slide All logos and Images mentioned on this slide belong to their respective owners.
  9. 9. www.MarketResearchReports.com Custom Research:  Are you an industry professional, entrepreneur, venture capitalist, investors and organization, then let us know your specific research requirements. Our goal is to cater to your requirements be it for a custom market research project, syndicated research report on a specific market or industry sector, newsletter creation, case study development or anything else related to marketing research. For Any Customization Related query Visit IdeaCenter @ http://www.marketresearchreports.com/idea-center
  10. 10. www.MarketResearchReports.com How To Buy This Report? Visit following URL to see Table of Content and purchase this publication: http://mrr.cm/Zds About Market Research Reports, Inc. Market Research Reports provides a customized set of reports from reputed Publishers, built on the intelligence available within organizations and leverages on our motto of “Intelligence Redefined”. Contact : Amitava Sen Email : info@marketresearchreports.com Phone: +1 302-703-7787 (USA) +91-8762746600 (India)

×